Horse Chestnut (Aesculus hippocastanum L.)
1. Identity, Botanical Classification, and Common Forms
Botanical and Chemical Identity
Horse chestnut (Aesculus hippocastanum) extract is a traditional botanical remedy derived from the seeds of a tree native to the Balkan peninsula. Aesculus L. in the soapberry family (Sapindaceae) is native to the temperate northern hemisphere. Members of the genus Aesculus grow as trees and shrubs, often attaining heights of 23 m. The fruit is a capsule with a thick, leathery husk that contains 1 to 6 dark seeds (nuts). As the husk dries, the nuts are released. The pink and white flowers of the plant grow in clusters. The tree is native to the woods of the Balkan region of southeastern Europe and to western Asia, but is now cultivated worldwide.
Horse chestnut should not be confused with sweet chestnut. The horse chestnut should not be confused with the California or Ohio chestnuts (Aesculus california and glabra), which are different species and more often called buckeye trees.
Horse chestnut (Aesculus chinensis) is an important medicinal tree that contains various bioactive compounds, such as aescin, barrigenol-type triterpenoid saponins (BAT), and aesculin, a glycosylated coumarin. The species most widely used in Western phytomedicine and the subject of the bulk of clinical research is Aesculus hippocastanum. The use of horse chestnut in Traditional Chinese Medicine (TCM) involves several species related to the European horse chestnut, most notably Aesculus chinensis and Aesculus wilsonii.
Parts Used
The bark of branches, fruits, and seeds are usually used medicinally (the leaves are at times, but this is much less common), while the bright white, yellow, or red flowers are mostly aesthetic. The dried ripe seeds of the plant are of most medicinal interest. Horse chestnut extract is used for the treatment of symptoms of varicose veins, hemorrhoids, and phlebitis. Extracts of the horse chestnut seeds are also used for diarrhea, fever, and urinary hesitancy. Creams with horse chestnut extract are used topically for muscle and joint aches due to arthritis or trauma.
Common Dosage Forms and Preparations
Commercial preparations of horse chestnut seed extract (HCSE) are available in multiple forms. Aesculaforce is a fresh plant HCSE that is available as an oral tincture, as tablets (20 mg or 50 mg), and as topical gel. Standardized oral capsules and tablets are the most common form used in clinical research. Today's standardized formulas ensure consistent aescin levels, typically 16–21%. This precision allows reliable dosing, bridging traditional knowledge with contemporary quality standards. A topical aescin preparation is very popular in Europe for the treatment of acute sprains during sporting events.
2. Traditional and Historical Use
European Folk Medicine
Horse chestnut, a tree native to the Balkan Peninsula, has been used in traditional medicine for centuries. The plant was introduced to England in the early 1600s and was traditionally a tree of kings and wealthy landowners. Later, it became Britain's municipal tree of choice and was planted decoratively along avenues and in parks all over the country. More serious medical use dates back to nineteenth-century France, where extracts were used to treat hemorrhoids.
The horse chestnut has been used as a traditional remedy for arthritis and rheumatism, as well as for gynecological bleeding and as a tonic. Even though the seeds are toxic, several traditional methods were employed to rid them of their toxicity. Seeds were buried in swampy, cold ground during the winter to free them of toxic, bitter components, and then eaten in the spring after boiling. American Indians roasted the poisonous nuts, peeled and mashed them, and then leached the meal in lime water for several days, creating a meal used to make bread.
In European folk medicine, carrying twigs of horse chestnut in one's pocket was believed to be useful for preventing and curing arthritis. Both the bark and the fruit from horse chestnut trees are used medicinally to strengthen and tone the circulatory system, especially the venous system.
Traditional Chinese Medicine
Traditional Chinese herbalists use horse chestnut not only for treatment of circulatory problems, but also as an astringent, a diuretic, for reduction of oedema or swelling, to reduce inflammation, as an expectorant in respiratory problems, and to fight viruses. These species have been used in TCM for various health concerns, particularly their properties in improving circulation and reducing inflammation, which are vital components of heart health. In TCM preparation, the seeds are broken to pieces and then heated until scorched, or soaked in wine and then roasted. Both of these lessen the blood-moving effects, and focus on the Qi-moving effects. This was a typical preparation in older TCM texts.
North American Indigenous Use
In the western United States, the crushed, unripe seeds of the California buckeye were scattered into streams to stupefy fish, and leaves were steeped as tea to remedy congestion. Horse chestnuts have been used historically as animal feed for farm animals; they are a valuable source of nutrients for deer, and some Native American peoples have included them in their diet. However, the outer covering of the horse chestnut nut is toxic, and the nut itself has to be boiled before being eaten.
Other Traditional Applications
Traditionally, horse chestnut was used for soap and shampoo because the seeds produce a soapy lather. Horse chestnut leaf is used for eczema, menstrual pain, soft tissue swelling from bone fracture and sprains, cough, arthritis, and joint pain in traditional herbal systems.
3. Key Constituents and Active Compounds
Triterpene Saponins (Aescin / Escin)
Aescin or escin is a mixture of saponins with anti-inflammatory, vasoconstrictor, and vasoprotective effects found in Aesculus hippocastanum. Aescin is the main active component in horse chestnut, and is responsible for most of its medicinal properties. The main active constituents isolated from horse chestnut are aescin (10%) and prosapogenin. Aescin (escin) is a mix of the triterpene saponins alpha- and beta-aescin and cryptoaescin. Aescin is a complex mixture of triterpene saponins. It consists of a water-soluble fraction (alpha-aescin) and a water-insoluble fraction (beta-aescin).
The individual saponins in the α-aescin group are the two isoaescins (Ia and Ib), while the two in the β-aescin group are the aescins (Ia and Ib). An impressive 13% in weight of escins in the dry seeds was measured, confirming that the HC escins must be absolutely considered for high-added value applications.
Flavonoids
Bioflavonoids present include quercetin and kaempferol, and their derivatives. Astragalin (kaempferol 3-O-glucoside) and isoquercitrin (quercetin-3-glucoside) found in Aesculus hippocastanum have been reported for several biological activities. Flavones, epicatechin, and its dimer proanthocyanidin A2 have been shown to inhibit hyaluronidase activity.
Coumarins
Antioxidants, such as proanthocyanidin, and coumarins, including the toxic esculin, as well as fraxin and pavietin, are also found in the Aesculus genus. Specific assays have been described to quantify the aescin content of preparations, including high-pressure liquid chromatography, thin-layer chromatography, and mass spectroscopy. The most important toxic principle is esculin. The coumarin aesculin is antioxidant, anti-inflammatory, and tonic to the venous vessels.
Other Constituents
The bark of Aesculus is also reported to possess the anti-inflammatory steroids stigmasterol, alpha-spinasterol, and beta-sitosterol. The seed oil contains 65% to 70% oleic acid. Horse chestnuts also contain flavonoids, sterols, and tannins.
Bioavailability
It was initially reported that the bioavailability of aescin was 12.5%, although subsequent studies in rats have reported bioavailabilities of less than 0.25%. The differences in absorption rates and values with Aescorin® (standard form of horse chestnut with 50 mg β-aescin) and Venostasin® (a delayed release formulation with 50 mg β-aescin) are not significant.
4. Established Mechanisms of Action
Enzyme Inhibition and Vascular Permeability
Horse chestnut seed extract has an inhibitory effect on catalytic enzymes such as collagenase, hyaluronidase, and beta-glucuronidase, which break down capillary walls. In chronic pathological conditions of the vascular system, this lysosomal enzyme activity is increased, causing a breakdown of the mucopolysaccharides in the capillary and venous walls. The saponins in horse chestnut inhibit the activity of these enzymes, which improves the integrity and function of these vessels by decreasing vascular permeability.
It is not exactly clear how escin works, but theories include that it works by "sealing" leaking capillaries, improving the elastic strength of veins, preventing the release of enzymes that damage the blood vessels, and blocking other various physiological events that lead to vein damage.
Venotonic Effects
The triterpene saponin aescin tones the veins by increasing the sensitivity of calcium ion channels and enhancing venous contractile activity, resulting in the venotonic action. Additionally, these saponins increase venous tone by increasing prostaglandin synthesis in the vascular tissue, which induces contraction of the venous tissues. This vasoconstriction increases the venous tone and raises the flow velocity of blood in the veins. The contraction of the veins, combined with the decreased permeability of the capillaries, improves the peripheral vascular tone and reduces venous swelling and oedema.
Anti-inflammatory Mechanisms
Beta-escin has been shown to inhibit NF-κB activation in different conditions, including an allergic airway inflammation model. Its anti-inflammatory effects involve downregulation of inflammatory gene expression and upregulation of granulocyte-macrophage colony-stimulating factor production, which also confers neuroprotection.
It has been confirmed that aescin is mainly responsible for the anti-inflammatory and anti-oedematous activity of the horse chestnut seed extract. Research results have shown that the complete extract has been around 100 times more effective as a treatment for inflammation and lymphoedema in rats than the extract from which aescin was removed.
Summary of Established Mechanisms
- Aescin reduces vascular permeability by blocking hyaluronidase and other enzymes that degrade capillary wall components.
- Venotonic activity: aescin increases venous tone by stimulating prostaglandin F2-alpha release, improving vein wall contractility.
- Anti-inflammatory: aescin inhibits NF-κB and reduces pro-inflammatory cytokine production in vascular tissue.
- Inhibition of cyclooxygenase activity of Japanese horse chestnut seed extract has been demonstrated in animal experiments.
- The flavonoids and tannins are recognized as having anti-inflammatory and astringent properties, respectively.
5. Scientific Evidence by Area of Use
5.1 Chronic Venous Insufficiency (CVI)
Chronic venous insufficiency is the most extensively studied indication for horse chestnut seed extract. The signs of CVI include swelling of the leg, feelings of tired and painful legs, dry scaly skin, varicose veins, hardening of the skin, and leg ulcers. CVI severity is often graded into 3 categories: stage I (swelling/edema); stage II (swelling plus skin changes); stage III (presence of open or healed leg ulcers). About 10% to 15% of adult men and 20% to 25% of adult women present signs and symptoms consistent with a diagnosis of CVI, and the prevalence increases with age.
Cochrane Reviews: Seventeen randomized controlled trials were included in the Cochrane review. Overall, the trials suggested an improvement in the symptoms of leg pain, oedema, and pruritus with horse chestnut seed extract when taken as capsules over two to 16 weeks.
Key outcome data: Overall, there appeared to be an improvement in CVI-related signs and symptoms with HCSE compared with placebo. Leg pain was assessed in seven placebo-controlled trials. Six reported a significant reduction of leg pain in the HCSE groups compared with the placebo groups, while another reported a statistically significant improvement compared with baseline. One trial suggested a weighted mean difference (WMD) of 42.4 mm (95% CI 34.9 to 49.9) measured on a 100 mm visual analogue scale. Leg volume was assessed in seven placebo-controlled trials. Six trials (n = 502) suggested a WMD of 32.1 ml (95% CI 13.49 to 50.72) in favour of HCSE compared with placebo.
Overall evidence quality: The evidence presented suggests that HCSE is an efficacious and safe short-term treatment for CVI. However, caveats exist and more rigorous, large RCTs are required to assess the efficacy of this treatment option. Future studies should be rigorously executed and reported in a uniform manner following the CONSORT statement. More controlled clinical trials are needed which should include larger numbers of participants and assess HCSE particularly for long-term use and as an adjunct to compression treatment.
The trials showed that for people with chronic venous insufficiency, the quality of the evidence is very low regarding the effect of HCSE on leg pain and edema.
Comparison with compression therapy: Both studies that compared HCSE with compression therapy on the reduction of lower leg volume were performed to compare the efficacy of HCSE with that of compression therapy. The studies had a similar design and included a placebo control. One study noted that horse chestnut extract was as effective as compression therapy at reducing swelling and leg volume.
Limitations: Oral horse chestnut seed extract is effective in the short-term treatment of mild to moderate long-term venous insufficiency, but not for post-thrombotic syndrome. Trial durations were generally short (2–16 weeks), and the methodological quality of many included studies has been characterized as variable.
5.2 Varicose Veins
Four clinical trials in patients with chronic venous insufficiency and one study in patients with varicose veins demonstrated the effectiveness of these preparations through the objective measure of reduction in lower leg edema and the subjective alleviation of leg pain, heaviness, and itching. In an 8-week study, 58% of participants who took horse chestnut seed extract tablets containing 20 mg of aescin 3 times daily and applied 2% aescin gel topically twice daily had reduced varicose vein symptoms like leg pain, swelling, heaviness, and discoloration.
5.3 Hemorrhoids
Horse chestnut seed extract has been shown to be effective in reducing symptoms in hemorrhoids (bleeding and swelling), bruising (pain and swelling), and postoperative edema in limited clinical trials. Traditionally, horse chestnut has been used for various ailments, including hemorrhoids, minor injuries, and edema. One small study showed that horse chestnut extract providing 120 mg of horse chestnut seed extract per day significantly improved symptoms of pain, itching, burning, and swelling. The evidence for hemorrhoids specifically is preliminary and based on small-scale trials; more rigorous investigation is needed to establish definitive conclusions.
5.4 Edema (Post-Surgical, Post-Traumatic, and Lymphedema)
Aescin also possesses anti-inflammatory properties and has been shown to reduce edema (swelling with fluid) following trauma, particularly following sports injury, surgery, and head injury. In vitro and animal studies, as well as leg elevation studies, have demonstrated the antiedematous and venotonic effect of the extract. Evidence for post-surgical and traumatic edema is largely based on limited clinical trials and preclinical data; it is considered preliminary.
5.5 Varicocele-Associated Male Infertility
Animal data suggest escin demonstrates activity in venous malfunction. A clinical study (n=219) evaluated the effect of 60 mg escin daily over 2 months on varicocele-associated infertility. The researchers reported a significant improvement in sperm density, but not motility, compared with surgical intervention and a control group (Vitamin E, pentoxifylline, and clomiphene).
A 2-month study in over 100 men with varicocele-associated infertility found that taking 30 mg of aescin every 12 hours improved sperm density, sperm motility, and sperm quality. In addition, the varicocele size decreased with the intake of aescin. Other studies suggest aescin may improve sperm quality in patients with varicocele-associated infertility. This evidence is preliminary, derived from a small number of trials, and requires replication in larger, well-controlled studies.
5.6 Antitumor and Anticancer Effects (Preclinical Only)
Beta-aescin has been evaluated in a number of in vitro studies and animal experiments for antiproliferative, apoptotic, and growth-inhibiting activities. Reductions in the number of aberrant crypt foci, as well as decreased tumor growth, has been demonstrated in rats with induced colon cancer. Lab studies suggest that aescin, or escin, in horse chestnut has anti-inflammatory, neuroprotective, and antitumor effects, and may enhance gemcitabine efficacy. These findings are exclusively preclinical (in vitro and animal models); no human clinical trials have established anticancer efficacy for horse chestnut.
5.7 Other Investigated Areas
In addition to benefits for CVI, clinical trials indicate that horse chestnut seed extract (HCSE) or its constituent escin may be beneficial for hearing loss and varicocele-related infertility. Evidence in these additional domains is limited and should be considered preliminary.
6. Body Systems and Health Areas of Association
- Venous/circulatory system: HCSE has venotonic, vascular protective, antispasmodic, anti-edematous, anti-allergic, anti-inflammatory, astringent, vasodilator, bitter, and diuretic properties.
- Skin and connective tissue: Topical applications for bruising, sprains, and varicose veins; inhibition of collagenase activity supports connective tissue integrity.
- Male reproductive system: Human studies of horse chestnut's use in treating ENT, cardiovascular, genitourinary, and dermatologic disorders have been summarized.
- Gastrointestinal: Traditional use for diarrhea; hemorrhoid treatment.
- Musculoskeletal: Creams with horse chestnut extract are used topically for muscle and joint aches due to arthritis or trauma.
7. Dosage Forms and Clinical Dosages
The most common dosage of horse chestnut is 300 mg HCSE twice daily, standardized to contain 50 mg escin per dose, for a total daily dose of 100 mg escin. The most common dosage of horse chestnut is 300 mg twice daily, standardized to contain 50 mg aescin per dose, for a total daily dose of 100 mg aescin.
Specific dosages reported in clinical studies include:
- Nine studies found that daily doses of 600 mg of horse chestnut extract containing 50 mg of aescin taken for up to 8 weeks reduced symptoms of CVI, including leg pain, swelling, and itchy legs.
- In an 8-week study, participants took horse chestnut seed extract tablets containing 20 mg of aescin 3 times daily and applied 2% aescin gel topically twice daily.
- A clinical study evaluated the effect of 60 mg escin daily over 2 months on varicocele-associated infertility.
- A 2-month study in over 100 men with varicocele-associated infertility used 30 mg of aescin every 12 hours.
- One small study on hemorrhoids used horse chestnut extract providing 120 mg per day.
All clinical trials on horse chestnut used standardized aescin content (16–20%); it is the quality benchmark for the supplement. Horse chestnut preparations should certify that a toxic constituent called esculin has been removed.
8. Safety Considerations and Drug Interactions
General Safety Profile
Horse chestnut is likely safe for most people when a standardized seed extract product is taken by mouth for a short amount of time. Standardized products have been tested to contain exact amounts of a verified chemical. Horse chestnut seed extract is generally well tolerated; the most common side effects are gastrointestinal disturbances, dizziness, and calf-muscle spasms. In one meta-analysis of 5,000 patients, the side effect incidence was 0.6%. Pruritus, nausea and other GI effects, headache, calf cramping, and dizziness were the most commonly listed problems. Patients using HCSE should be monitored for liver function abnormalities on a routine basis.
The adverse events reported across 14 trials were mild and infrequent. They included gastrointestinal complaints, dizziness, nausea, headache, and pruritus from six studies.
Toxicity of Raw/Unprocessed Material
Raw horse chestnut seed, bark, flower, and leaf are unsafe and can even cause death when taken by mouth by adults or children. Unprocessed horse chestnut seeds contain a toxin called esculin. This toxin may increase the risk of bleeding due to its ability to prevent blood clots from forming. The unprocessed seeds are poisonous, and symptoms associated with horse chestnut seed poisoning include vomiting, diarrhea, headache, confusion, weakness, muscle twitching, poor coordination, coma, and paralysis. Horse chestnut seeds are therefore processed to remove the toxic component, resulting in purified horse chestnut seed extract.
Chestnut seed poisoning has been documented in a 46-year-old male who mistook horse chestnut seed for Korean chestnut. Symptoms included epigastric pain, nausea, sweating, and palpitations as well as slight increases in liver enzymes, serum amylase, and pancreatic amylase.
Hepatotoxicity
The constituents of horse chestnut extracts are many and include triterpene saponins, hydroxycoumarins, flavonoids, and tannins. Importantly, horse chestnut seeds contain the toxic triterpene saponin known as escin and its glycoside esculin. Rare but serious: hepatotoxicity (liver damage) has been reported in isolated cases — it is advised to discontinue if jaundice appears. Patients with compromised renal or hepatic function should not consume horse chestnut products.
Renal Concerns
There is limited evidence of direct kidney toxicity at standard doses. However, those with pre-existing kidney disease should avoid it, as aescin is partially excreted renally. High doses are theoretically problematic for impaired kidneys.
Drug Interactions
HCSE should not be used concomitantly with anticoagulants, including warfarin (Coumadin), heparin, and aspirin, because the herb has a tendency to potentiate the anticoagulant action and can be hazardous. Patients on anticoagulation who wish to take the supplement should do so only under medical supervision. Clinical trials have shown that horse chestnut seed extract and placebo are associated with similar side effects. Horse chestnut may interact with anticoagulants and antidiabetics, and caution is advised in patients taking these drugs.
In theory, horse chestnut may increase the risk of bleeding. In addition, animal studies suggest that HCSE may cause lowered blood sugar.
Horse chestnut extract might slow blood clotting, increasing the risk of bruising and bleeding in people taking aspirin, ibuprofen, coumadin, or other drugs.
Allergic and Other Reactions
Pollen from the horse chestnut flower can cause allergic reactions. Aescin has been anecdotally implicated as a potential source of occupational asthma. Rectal (suppository) use of horse chestnut may cause inflammation and itching in the anal area.
Pregnancy, Breastfeeding, and Special Populations
Little is known about whether it's safe to use horse chestnut seed extract during pregnancy or while breastfeeding. Contraindications commonly cited include pregnancy, breastfeeding, kidney disease, liver disease, and concurrent blood thinner use.
Regulatory Status
The US Food and Drug Administration categorizes whole horse chestnut as an unsafe herb. Since April 2014, all herbal medicines for sale in the UK and Europe must be approved by the Medicines & Healthcare Products Regulatory Agency (MHRA) having been rigorously checked for safety and quality. They must also display the Traditional Herbal Registration 'THR' logo on their pack. Registered herbal medicinal products containing horse chestnut are used for relieving the symptoms of varicose veins, based on traditional use only.
References
Volver